Home
/
CYTOKINETICS INC
/
Financials
/
Quarterly
CYTOKINETICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CYTOKINETICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$10.64M
Nov 9, 2018
Q2
2018
Jun 30, 2018
$6.22M
Aug 7, 2018
Q1
2018
Mar 31, 2018
$5.27M
May 10, 2018
Q3
2018
Sep 30, 2017
$6.18M
Nov 9, 2018
Q2
2018
Jun 30, 2017
$3.05M
Aug 7, 2018
Q1
2018
Mar 31, 2017
$4.15M
May 10, 2018
Q3
2017
Sep 30, 2016
$59.05M
Nov 3, 2017
Q2
2017
Jun 30, 2016
$5.80M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$8.42M
May 4, 2017
Q3
2016
Sep 30, 2015
$7.95M
Dec 15, 2016
Q2
2016
Jun 30, 2015
$6.54M
Aug 4, 2016
Q1
2016
Mar 31, 2015
$4.41M
May 5, 2016
Q3
2015
Sep 30, 2014
$9.42M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$7.79M
Aug 5, 2015
Q1
2015
Mar 31, 2014
$7.98M
May 4, 2015
Q3
2014
Sep 30, 2013
$4.47M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$1.01M
Aug 7, 2014
Q1
2014
Mar 31, 2013
$821.0K
May 7, 2014
Q3
2013
Sep 30, 2012
$1.71M
Nov 6, 2013
Q2
2013
Jun 30, 2012
$1.84M
Aug 7, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.94M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$66.77M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.58M
May 6, 2025
Q3
2025
Sep 30, 2024
$463.0K
Nov 5, 2025
Q2
2025
Jun 30, 2024
$249.0K
Aug 7, 2025
Q1
2025
Mar 31, 2024
$835.0K
May 6, 2025
Q3
2024
Sep 30, 2023
$378.0K
Nov 7, 2024
Q2
2024
Jun 30, 2023
$867.0K
Aug 9, 2024
Q1
2024
Mar 31, 2023
$4.61M
May 10, 2024
Q3
2023
Sep 30, 2022
$2.52M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$88.97M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$1.15M
May 5, 2023
Q3
2022
Sep 30, 2021
$5.44M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$2.84M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$6.55M
May 6, 2022
Q3
2021
Sep 30, 2020
$41.69M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$3.59M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$3.83M
May 7, 2021
Q3
2020
Sep 30, 2019
$6.06M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$7.14M
Aug 7, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($306.18M)
Nov 5, 2025
Q3
2025
Jun 30, 2025
($134.37M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($134.37M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($161.38M)
May 6, 2025
Q3
2025
Mar 31, 2025
($161.38M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($161.38M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($160.55M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($143.32M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($143.32M)
Nov 5, 2025
Q2
2025
Mar 31, 2024
($135.64M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($135.64M)
Nov 5, 2025
Q1
2025
Mar 31, 2024
($135.64M)
May 6, 2025
Q3
2024
Sep 30, 2023
($129.42M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($128.64M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($128.64M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($131.29M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($131.29M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($131.29M)
May 10, 2024
Q3
2023
Sep 30, 2022
($142.31M)
Nov 3, 2023
Q3
2023
Jun 30, 2022
($19.82M)
Nov 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($166.76M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($111.51M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($155.63M)
May 6, 2025
Q3
2025
Sep 30, 2024
($140.80M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($130.17M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($126.24M)
May 6, 2025
Q3
2024
Sep 30, 2023
($122.27M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($122.05M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($124.47M)
May 10, 2024
Q3
2023
Sep 30, 2022
($108.44M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($10.87M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($77.86M)
May 5, 2023
Q3
2022
Sep 30, 2021
($69.20M)
Nov 4, 2022
Q2
2022
Jun 30, 2021
($54.80M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($40.61M)
May 6, 2022
Q3
2021
Sep 30, 2020
$5.18M
Nov 5, 2021
Q2
2021
Jun 30, 2020
($32.36M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($30.36M)
May 7, 2021
Q3
2020
Sep 30, 2019
($23.93M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($26.72M)
Aug 7, 2020